GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » TiumBio Co Ltd (XKRX:321550) » Definitions » Other Income (Expense)

TiumBio Co (XKRX:321550) Other Income (Expense) : ₩-7,931 Mil (TTM As of Sep. 2024)


View and export this data going back to 2019. Start your Free Trial

What is TiumBio Co Other Income (Expense)?

TiumBio Co's other income expense for the TiumBio Co's pretax income for the three months ended in Sep. 2024 was ₩103 Mil. Its other income expense for the trailing twelve months (TTM) ended in Sep. 2024 was ₩-7,931 Mil.

TiumBio Co Other Income (Expense) Historical Data

The historical data trend for TiumBio Co's Other Income (Expense) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

TiumBio Co Other Income (Expense) Chart

TiumBio Co Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Other Income (Expense)
Get a 7-Day Free Trial -17.42 10.88 42.48 -6,258.17 -1,751.95

TiumBio Co Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Other Income (Expense) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 28.72 4,335.11 -3,568.18 -8,801.77 103.46

TiumBio Co Other Income (Expense) Calculation

Other income expense includes minority interest. Minority interest is a significant but non-controlling ownership of less than 50% of a company's voting shares by either an investor or another company.

Other Income (Expense) for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩-7,931 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

TiumBio Co  (XKRX:321550) Other Income (Expense) Explanation

Minority interest is reported on the consolidated income statement as a share of profit belonging to minority shareholders.

TiumBio Co Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » TiumBio Co Ltd (XKRX:321550) » Definitions » Other Income (Expense)
Comparable Companies
XKRX:314130 XKRX:078160 XKRX:138610 XKRX:214260 XKRX:046210 XKRX:084990 XKRX:235980 XKRX:174900 XKRX:388870 XKRX:226950 OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA HKSE:02269 XBRU:ARGX BNTX
Traded in Other Exchanges
N/A
Address
49, Daewangpangyo-ro 644beon-gil, Bundang-gu, 4th floor, Gyeonggi, Seongnam, KOR, 13493
Website
http://www.tiumbio.com
TiumBio Co Ltd is a Biopharmaceutical company. It is engaged in research and development of rare and intractable diseases. The company's products are in pipeline. It offers products such as Idiopathic pulmonary fibrosis therapies, immune chemotherapy, endometriosis therapies, hemophilia.

TiumBio Co Headlines

No Headlines